Our findings suggest a “copper-Atox1-ROS-NLRP3 inflammasome” regulatory axis in inflammatory disorders and demonstrate that Atox1 may regulate macrophage polarization, suggesting its potential as a therapeutic target for IBD and highlighting the importance of Atox1 as a key mediator in the complex network of inflammatory processes. Here, NLRP3 is linked to inflammatory bowel disease.